CXCR2 inhibition enables NASH-HCC immunotherapy
Objective Hepatocellular carcinoma (HCC) is increasingly associated with non-alcoholic steatohepatitis (NASH). HCC immunotherapy offers great promise; however, recent data suggests NASH-HCC may be less sensitive to conventional immune checkpoint inhibition (ICI). We hypothesised that targeting neutr...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
27 April 2022
|
| In: |
Gut
Year: 2022, Jahrgang: 71, Heft: 10, Pages: 2093-2106 |
| ISSN: | 1468-3288 |
| DOI: | 10.1136/gutjnl-2021-326259 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1136/gutjnl-2021-326259 Verlag, lizenzpflichtig, Volltext: https://gut.bmj.com/content/71/10/2093 
|
| Verfasserangaben: | Jack Leslie, John BG Mackey, Thomas Jamieson, Erik Ramon-Gil, Thomas M Drake, Frédéric Fercoq, William Clark, Kathryn Gilroy, Ann Hedley, Colin Nixon, Saimir Luli, Maja Laszczewska, Roser Pinyol, Roger Esteban-Fabró, Catherine E Willoughby, Philipp K Haber, Carmen Andreu-Oller, Mohammad Rahbari, Chaofan Fan, Dominik Pfister, Shreya Raman, Niall Wilson, Miryam Müller, Amy Collins, Daniel Geh, Andrew Fuller, David McDonald, Gillian Hulme, Andrew Filby, Xabier Cortes-Lavaud, Noha-Ehssan Mohamed, Catriona A Ford, Ximena L Raffo Iraolagoitia, Amanda J McFarlane, Misti V McCain, Rachel A Ridgway, Edward W Roberts, Simon T Barry, Gerard J Graham, Mathias Heikenwälder, Helen L Reeves, Josep M Llovet, Leo M Carlin, Thomas G Bird, Owen J Sansom, Derek A Mann |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1895386543 | ||
| 003 | DE-627 | ||
| 005 | 20250718091325.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240715s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1136/gutjnl-2021-326259 |2 doi | |
| 035 | |a (DE-627)1895386543 | ||
| 035 | |a (DE-599)KXP1895386543 | ||
| 035 | |a (OCoLC)1475302359 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 32 |2 sdnb | ||
| 100 | 1 | |a Leslie, Jack |e VerfasserIn |0 (DE-588)133572723X |0 (DE-627)189538639X |4 aut | |
| 245 | 1 | 0 | |a CXCR2 inhibition enables NASH-HCC immunotherapy |c Jack Leslie, John BG Mackey, Thomas Jamieson, Erik Ramon-Gil, Thomas M Drake, Frédéric Fercoq, William Clark, Kathryn Gilroy, Ann Hedley, Colin Nixon, Saimir Luli, Maja Laszczewska, Roser Pinyol, Roger Esteban-Fabró, Catherine E Willoughby, Philipp K Haber, Carmen Andreu-Oller, Mohammad Rahbari, Chaofan Fan, Dominik Pfister, Shreya Raman, Niall Wilson, Miryam Müller, Amy Collins, Daniel Geh, Andrew Fuller, David McDonald, Gillian Hulme, Andrew Filby, Xabier Cortes-Lavaud, Noha-Ehssan Mohamed, Catriona A Ford, Ximena L Raffo Iraolagoitia, Amanda J McFarlane, Misti V McCain, Rachel A Ridgway, Edward W Roberts, Simon T Barry, Gerard J Graham, Mathias Heikenwälder, Helen L Reeves, Josep M Llovet, Leo M Carlin, Thomas G Bird, Owen J Sansom, Derek A Mann |
| 264 | 1 | |c 27 April 2022 | |
| 300 | |a 14 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 15.07.2024 | ||
| 520 | |a Objective Hepatocellular carcinoma (HCC) is increasingly associated with non-alcoholic steatohepatitis (NASH). HCC immunotherapy offers great promise; however, recent data suggests NASH-HCC may be less sensitive to conventional immune checkpoint inhibition (ICI). We hypothesised that targeting neutrophils using a CXCR2 small molecule inhibitor may sensitise NASH-HCC to ICI therapy. - Design Neutrophil infiltration was characterised in human HCC and mouse models of HCC. Late-stage intervention with anti-PD1 and/or a CXCR2 inhibitor was performed in murine models of NASH-HCC. The tumour immune microenvironment was characterised by imaging mass cytometry, RNA-seq and flow cytometry. - Results Neutrophils expressing CXCR2, a receptor crucial to neutrophil recruitment in acute-injury, are highly represented in human NASH-HCC. In models of NASH-HCC lacking response to ICI, the combination of a CXCR2 antagonist with anti-PD1 suppressed tumour burden and extended survival. Combination therapy increased intratumoural XCR1+ dendritic cell activation and CD8+ T cell numbers which are associated with anti-tumoural immunity, this was confirmed by loss of therapeutic effect on genetic impairment of myeloid cell recruitment, neutralisation of the XCR1-ligand XCL1 or depletion of CD8+ T cells. Therapeutic benefit was accompanied by an unexpected increase in tumour-associated neutrophils (TANs) which switched from a protumour to anti-tumour progenitor-like neutrophil phenotype. Reprogrammed TANs were found in direct contact with CD8+ T cells in clusters that were enriched for the cytotoxic anti-tumoural protease granzyme B. Neutrophil reprogramming was not observed in the circulation indicative of the combination therapy selectively influencing TANs. - Conclusion CXCR2-inhibition induces reprogramming of the tumour immune microenvironment that promotes ICI in NASH-HCC. | ||
| 650 | 4 | |a hepatocellular carcinoma | |
| 650 | 4 | |a immunotherapy | |
| 650 | 4 | |a nonalcoholic steatohepatitis | |
| 700 | 1 | |a Mackey, John B. G. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Jamieson, Thomas |e VerfasserIn |4 aut | |
| 700 | 1 | |a Ramon-Gil, Erik |e VerfasserIn |4 aut | |
| 700 | 1 | |a Drake, Thomas M. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Fercoq, Frédéric |e VerfasserIn |4 aut | |
| 700 | 1 | |a Clark, William |e VerfasserIn |4 aut | |
| 700 | 1 | |a Gilroy, Kathryn |e VerfasserIn |4 aut | |
| 700 | 1 | |a Hedley, Ann |e VerfasserIn |4 aut | |
| 700 | 1 | |a Nixon, Colin |e VerfasserIn |4 aut | |
| 700 | 1 | |a Luli, Saimir |e VerfasserIn |4 aut | |
| 700 | 1 | |a Laszczewska, Maja |e VerfasserIn |4 aut | |
| 700 | 1 | |a Pinyol, Roser |e VerfasserIn |4 aut | |
| 700 | 1 | |a Esteban-Fabró, Roger |e VerfasserIn |4 aut | |
| 700 | 1 | |a Willoughby, Catherine E. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Haber, Philipp K. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Andreu-Oller, Carmen |e VerfasserIn |4 aut | |
| 700 | 1 | |a Rahbari, Mohammad |e VerfasserIn |0 (DE-588)1192953541 |0 (DE-627)1671484282 |4 aut | |
| 700 | 1 | |a Fan, Chaofan |d 1991- |e VerfasserIn |0 (DE-588)1371822174 |0 (DE-627)1931199655 |4 aut | |
| 700 | 1 | |a Pfister, Dominik |d 1988- |e VerfasserIn |0 (DE-588)1193748658 |0 (DE-627)1672826136 |4 aut | |
| 700 | 1 | |a Raman, Shreya |e VerfasserIn |4 aut | |
| 700 | 1 | |a Wilson, Niall |e VerfasserIn |4 aut | |
| 700 | 1 | |a Müller, Miryam |e VerfasserIn |4 aut | |
| 700 | 1 | |a Collins, Amy |e VerfasserIn |4 aut | |
| 700 | 1 | |a Geh, Daniel |e VerfasserIn |4 aut | |
| 700 | 1 | |a Fuller, Andrew |e VerfasserIn |4 aut | |
| 700 | 1 | |a McDonald, David |e VerfasserIn |4 aut | |
| 700 | 1 | |a Hulme, Gillian |e VerfasserIn |4 aut | |
| 700 | 1 | |a Filby, Andrew |e VerfasserIn |4 aut | |
| 700 | 1 | |a Cortes-Lavaud, Xabier |e VerfasserIn |4 aut | |
| 700 | 1 | |a Mohamed, Noha-Ehssan |e VerfasserIn |4 aut | |
| 700 | 1 | |a Ford, Catriona A. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Iraolagoitia, Ximena L. Raffo |e VerfasserIn |4 aut | |
| 700 | 1 | |a McFarlane, Amanda J. |e VerfasserIn |4 aut | |
| 700 | 1 | |a McCain, Misti V. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Ridgway, Rachel A. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Roberts, Edward W. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Barry, Simon T. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Graham, Gerard J. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Heikenwälder, Mathias |d 1976- |e VerfasserIn |0 (DE-588)1024541045 |0 (DE-627)720089840 |0 (DE-576)368599299 |4 aut | |
| 700 | 1 | |a Reeves, Helen L. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Llovet, Josep M. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Carlin, Leo M. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Bird, Thomas G. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Sansom, Owen J. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Mann, Derek A. |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Gut |d London : BMJ Publishing Group, 1960 |g 71(2022), 10, Seite 2093-2106 |h Online-Ressource |w (DE-627)302725628 |w (DE-600)1492637-4 |w (DE-576)082435405 |x 1468-3288 |7 nnas |a CXCR2 inhibition enables NASH-HCC immunotherapy |
| 773 | 1 | 8 | |g volume:71 |g year:2022 |g number:10 |g pages:2093-2106 |g extent:14 |a CXCR2 inhibition enables NASH-HCC immunotherapy |
| 856 | 4 | 0 | |u https://doi.org/10.1136/gutjnl-2021-326259 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://gut.bmj.com/content/71/10/2093 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20240715 | ||
| 993 | |a Article | ||
| 994 | |a 2022 | ||
| 998 | |g 1024541045 |a Heikenwälder, Mathias |m 1024541045:Heikenwälder, Mathias |d 910000 |d 911700 |e 910000PH1024541045 |e 911700PH1024541045 |k 0/910000/ |k 1/910000/911700/ |p 40 | ||
| 998 | |g 1193748658 |a Pfister, Dominik |m 1193748658:Pfister, Dominik |p 20 | ||
| 998 | |g 1371822174 |a Fan, Chaofan |m 1371822174:Fan, Chaofan |d 50000 |e 50000PF1371822174 |k 0/50000/ |p 19 | ||
| 998 | |g 1192953541 |a Rahbari, Mohammad |m 1192953541:Rahbari, Mohammad |d 60000 |d 61800 |e 60000PR1192953541 |e 61800PR1192953541 |k 0/60000/ |k 1/60000/61800/ |p 18 | ||
| 999 | |a KXP-PPN1895386543 |e 4551023582 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"person":[{"display":"Leslie, Jack","family":"Leslie","given":"Jack","role":"aut"},{"display":"Mackey, John B. G.","family":"Mackey","given":"John B. G.","role":"aut"},{"role":"aut","given":"Thomas","family":"Jamieson","display":"Jamieson, Thomas"},{"given":"Erik","role":"aut","display":"Ramon-Gil, Erik","family":"Ramon-Gil"},{"role":"aut","given":"Thomas M.","family":"Drake","display":"Drake, Thomas M."},{"role":"aut","given":"Frédéric","family":"Fercoq","display":"Fercoq, Frédéric"},{"given":"William","role":"aut","display":"Clark, William","family":"Clark"},{"family":"Gilroy","display":"Gilroy, Kathryn","role":"aut","given":"Kathryn"},{"display":"Hedley, Ann","family":"Hedley","given":"Ann","role":"aut"},{"given":"Colin","role":"aut","display":"Nixon, Colin","family":"Nixon"},{"family":"Luli","display":"Luli, Saimir","role":"aut","given":"Saimir"},{"role":"aut","given":"Maja","family":"Laszczewska","display":"Laszczewska, Maja"},{"given":"Roser","role":"aut","display":"Pinyol, Roser","family":"Pinyol"},{"family":"Esteban-Fabró","display":"Esteban-Fabró, Roger","role":"aut","given":"Roger"},{"family":"Willoughby","display":"Willoughby, Catherine E.","role":"aut","given":"Catherine E."},{"family":"Haber","display":"Haber, Philipp K.","role":"aut","given":"Philipp K."},{"display":"Andreu-Oller, Carmen","family":"Andreu-Oller","given":"Carmen","role":"aut"},{"role":"aut","given":"Mohammad","family":"Rahbari","display":"Rahbari, Mohammad"},{"family":"Fan","display":"Fan, Chaofan","role":"aut","given":"Chaofan"},{"given":"Dominik","role":"aut","display":"Pfister, Dominik","family":"Pfister"},{"given":"Shreya","role":"aut","display":"Raman, Shreya","family":"Raman"},{"given":"Niall","role":"aut","display":"Wilson, Niall","family":"Wilson"},{"display":"Müller, Miryam","family":"Müller","given":"Miryam","role":"aut"},{"display":"Collins, Amy","family":"Collins","given":"Amy","role":"aut"},{"given":"Daniel","role":"aut","display":"Geh, Daniel","family":"Geh"},{"display":"Fuller, Andrew","family":"Fuller","given":"Andrew","role":"aut"},{"family":"McDonald","display":"McDonald, David","role":"aut","given":"David"},{"family":"Hulme","display":"Hulme, Gillian","role":"aut","given":"Gillian"},{"given":"Andrew","role":"aut","display":"Filby, Andrew","family":"Filby"},{"display":"Cortes-Lavaud, Xabier","family":"Cortes-Lavaud","given":"Xabier","role":"aut"},{"given":"Noha-Ehssan","role":"aut","display":"Mohamed, Noha-Ehssan","family":"Mohamed"},{"display":"Ford, Catriona A.","family":"Ford","given":"Catriona A.","role":"aut"},{"family":"Iraolagoitia","display":"Iraolagoitia, Ximena L. Raffo","role":"aut","given":"Ximena L. Raffo"},{"role":"aut","given":"Amanda J.","family":"McFarlane","display":"McFarlane, Amanda J."},{"role":"aut","given":"Misti V.","family":"McCain","display":"McCain, Misti V."},{"given":"Rachel A.","role":"aut","display":"Ridgway, Rachel A.","family":"Ridgway"},{"given":"Edward W.","role":"aut","display":"Roberts, Edward W.","family":"Roberts"},{"role":"aut","given":"Simon T.","family":"Barry","display":"Barry, Simon T."},{"family":"Graham","display":"Graham, Gerard J.","role":"aut","given":"Gerard J."},{"family":"Heikenwälder","display":"Heikenwälder, Mathias","role":"aut","given":"Mathias"},{"given":"Helen L.","role":"aut","display":"Reeves, Helen L.","family":"Reeves"},{"role":"aut","given":"Josep M.","family":"Llovet","display":"Llovet, Josep M."},{"given":"Leo M.","role":"aut","display":"Carlin, Leo M.","family":"Carlin"},{"given":"Thomas G.","role":"aut","display":"Bird, Thomas G.","family":"Bird"},{"given":"Owen J.","role":"aut","display":"Sansom, Owen J.","family":"Sansom"},{"display":"Mann, Derek A.","family":"Mann","given":"Derek A.","role":"aut"}],"id":{"eki":["1895386543"],"doi":["10.1136/gutjnl-2021-326259"]},"type":{"bibl":"article-journal","media":"Online-Ressource"},"title":[{"title_sort":"CXCR2 inhibition enables NASH-HCC immunotherapy","title":"CXCR2 inhibition enables NASH-HCC immunotherapy"}],"relHost":[{"disp":"CXCR2 inhibition enables NASH-HCC immunotherapyGut","titleAlt":[{"title":"Gut online"},{"title":"eGut"}],"part":{"issue":"10","pages":"2093-2106","volume":"71","text":"71(2022), 10, Seite 2093-2106","year":"2022","extent":"14"},"physDesc":[{"extent":"Online-Ressource"}],"title":[{"subtitle":"an international journal of gastroenterology and hepatology","title_sort":"Gut","title":"Gut"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"id":{"zdb":["1492637-4"],"issn":["1468-3288"],"eki":["302725628"]},"origin":[{"publisherPlace":"London","publisher":"BMJ Publishing Group","dateIssuedDisp":"1960-","dateIssuedKey":"1960"}],"recId":"302725628","language":["eng"],"note":["Gesehen am 07.09.12"],"pubHistory":["1.1960 -"]}],"physDesc":[{"extent":"14 S."}],"name":{"displayForm":["Jack Leslie, John BG Mackey, Thomas Jamieson, Erik Ramon-Gil, Thomas M Drake, Frédéric Fercoq, William Clark, Kathryn Gilroy, Ann Hedley, Colin Nixon, Saimir Luli, Maja Laszczewska, Roser Pinyol, Roger Esteban-Fabró, Catherine E Willoughby, Philipp K Haber, Carmen Andreu-Oller, Mohammad Rahbari, Chaofan Fan, Dominik Pfister, Shreya Raman, Niall Wilson, Miryam Müller, Amy Collins, Daniel Geh, Andrew Fuller, David McDonald, Gillian Hulme, Andrew Filby, Xabier Cortes-Lavaud, Noha-Ehssan Mohamed, Catriona A Ford, Ximena L Raffo Iraolagoitia, Amanda J McFarlane, Misti V McCain, Rachel A Ridgway, Edward W Roberts, Simon T Barry, Gerard J Graham, Mathias Heikenwälder, Helen L Reeves, Josep M Llovet, Leo M Carlin, Thomas G Bird, Owen J Sansom, Derek A Mann"]},"note":["Gesehen am 15.07.2024"],"recId":"1895386543","language":["eng"],"origin":[{"dateIssuedDisp":"27 April 2022","dateIssuedKey":"2022"}]} | ||
| SRT | |a LESLIEJACKCXCR2INHIB2720 | ||